| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GTHX | G1 Therapeutics, Inc. | Umstead John W. V | Chief Financial Officer | Mar 18, 2024 | Sale | $3.02 | 6,547 | 19,752 | 123,896 | Mar 20, 2024, 04:32 PM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | Feb 12, 2024 | Option Exercise | $2.46 | 57,200 | 140,723 | 198,538 | Feb 13, 2024, 06:14 PM | |
| GTHX | G1 Therapeutics, Inc. | Umstead John W. V | Chief Financial Officer | Jan 03, 2024 | Sale | $3.12 | 632 | 1,971 | 130,933 | Jan 08, 2024, 06:04 AM | |
| GTHX | G1 Therapeutics, Inc. | Umstead John W. V | Chief Financial Officer | Jan 04, 2024 | Sale | $2.94 | 111 | 327 | 130,443 | Jan 08, 2024, 06:04 AM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | Jan 03, 2024 | Sale | $3.12 | 3,019 | 9,416 | 172,920 | Jan 08, 2024, 06:03 AM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | Jan 04, 2024 | Sale | $2.94 | 721 | 2,121 | 169,938 | Jan 08, 2024, 06:03 AM | |
| GTHX | G1 Therapeutics, Inc. | Perry Andrew | Chief Commercial Officer | Jan 03, 2024 | Sale | $3.12 | 2,413 | 7,526 | 89,136 | Jan 08, 2024, 06:03 AM | |
| GTHX | G1 Therapeutics, Inc. | Bailey John E. (Jack) Jr. | President and CEO | Jan 03, 2024 | Sale | $3.12 | 11,686 | 36,447 | 498,688 | Jan 08, 2024, 06:02 AM | |
| GTHX | G1 Therapeutics, Inc. | Avagliano Mark | Chief Business Officer | Jan 04, 2024 | Sale | $2.94 | 721 | 2,121 | 117,834 | Jan 08, 2024, 06:02 AM | |
| GTHX | G1 Therapeutics, Inc. | Avagliano Mark | Chief Business Officer | Jan 03, 2024 | Sale | $3.12 | 3,360 | 10,480 | 121,157 | Jan 08, 2024, 06:02 AM | |
| GTHX | G1 Therapeutics, Inc. | MURDOCK TERRY L | Chief Operating Officer | Jan 03, 2024 | Sale | $3.12 | 3,019 | 9,416 | 106,620 | Jan 08, 2024, 06:00 AM | |
| GTHX | G1 Therapeutics, Inc. | MURDOCK TERRY L | Chief Operating Officer | Jan 04, 2024 | Sale | $2.94 | 721 | 2,121 | 103,638 | Jan 08, 2024, 06:00 AM | |
| GTHX | G1 Therapeutics, Inc. | Bailey John E. (Jack) Jr. | President and CEO | Jan 02, 2024 | Sale | $3.27 | 32,983 | 108,006 | 400,580 | Jan 02, 2024, 07:44 PM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | Dec 11, 2023 | Sale | $1.89 | 67,678 | 127,603 | 157,817 | Dec 13, 2023, 04:45 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Director | Aug 08, 2023 | Sale | $1.19 | 120,000 | 143,130 | 173,286 | Aug 10, 2023, 04:11 PM | |
| GTHX | G1 Therapeutics, Inc. | Perry Andrew | Chief Commercial Officer | Jul 05, 2023 | Sale | $2.45 | 355 | 871 | 55,945 | Jul 07, 2023, 04:08 PM | |
| GTHX | G1 Therapeutics, Inc. | MURDOCK TERRY L | Chief Operating Officer | Jul 05, 2023 | Sale | $2.45 | 1,361 | 3,339 | 70,078 | Jul 07, 2023, 04:08 PM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | Jul 05, 2023 | Sale | $2.45 | 1,361 | 3,339 | 136,378 | Jul 07, 2023, 04:08 PM | |
| GTHX | G1 Therapeutics, Inc. | Bailey John E. (Jack) Jr. | President and CEO | Jul 05, 2023 | Sale | $2.45 | 2,719 | 6,672 | 433,563 | Jul 07, 2023, 04:07 PM | |
| GTHX | G1 Therapeutics, Inc. | Moses Jennifer K. | CFO | Jan 04, 2023 | Sale | $5.58 | 1,639 | 9,138 | 58,549 | Jan 05, 2023, 08:26 PM | |
| GTHX | G1 Therapeutics, Inc. | Moses Jennifer K. | CFO | Jan 05, 2023 | Sale | $5.41 | 729 | 3,942 | 57,820 | Jan 05, 2023, 08:26 PM | |
| GTHX | G1 Therapeutics, Inc. | MURDOCK TERRY L | Chief Operating Officer | Jan 04, 2023 | Sale | $5.58 | 1,639 | 9,138 | 37,168 | Jan 05, 2023, 08:26 PM | |
| GTHX | G1 Therapeutics, Inc. | MURDOCK TERRY L | Chief Operating Officer | Jan 05, 2023 | Sale | $5.41 | 729 | 3,942 | 36,439 | Jan 05, 2023, 08:26 PM | |
| GTHX | G1 Therapeutics, Inc. | Perry Andrew | Chief Commercial Officer | Jan 04, 2023 | Sale | $5.58 | 820 | 4,572 | 21,300 | Jan 05, 2023, 08:25 PM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | Jan 04, 2023 | Sale | $5.58 | 1,639 | 9,138 | 103,468 | Jan 05, 2023, 08:25 PM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | Jan 05, 2023 | Sale | $5.41 | 729 | 3,942 | 102,739 | Jan 05, 2023, 08:25 PM | |
| GTHX | G1 Therapeutics, Inc. | Hanson James S. | General Counsel | Jan 04, 2023 | Sale | $5.58 | 1,639 | 9,138 | 41,816 | Jan 05, 2023, 08:25 PM | |
| GTHX | G1 Therapeutics, Inc. | Hanson James S. | General Counsel | Jan 05, 2023 | Sale | $5.41 | 729 | 3,942 | 41,087 | Jan 05, 2023, 08:25 PM | |
| GTHX | G1 Therapeutics, Inc. | Bailey John E. (Jack) Jr. | President and CEO | Jan 03, 2023 | Sale | $5.85 | 32,019 | 187,452 | 281,889 | Jan 05, 2023, 08:23 PM | |
| GTHX | G1 Therapeutics, Inc. | Bailey John E. (Jack) Jr. | President and CEO | Jan 04, 2023 | Sale | $5.58 | 5,607 | 31,262 | 276,282 | Jan 05, 2023, 08:23 PM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | Dec 15, 2022 | Option Exercise | $0.30 | 14,000 | 4,200 | 87,207 | Dec 16, 2022, 04:12 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Director | Oct 18, 2022 | Option Exercise | $6.04 | 30,000 | 181,339 | 131,000 | Oct 20, 2022, 04:05 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Director | Sep 20, 2022 | Option Exercise | $6.95 | 40,000 | 277,844 | 136,000 | Sep 22, 2022, 04:40 PM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | Sep 13, 2022 | Option Exercise | $8.05 | 36,000 | 289,766 | 91,207 | Sep 16, 2022, 04:31 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Director | Aug 16, 2022 | Option Exercise | $6.51 | 160,000 | 1,042,104 | 196,000 | Aug 18, 2022, 04:06 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Director | Feb 07, 2022 | Option Exercise | $0.39 | 15,000 | 5,850 | 116,000 | Feb 08, 2022, 04:05 PM | |
| GTHX | G1 Therapeutics, Inc. | Moses Jennifer K. | CFO | Feb 01, 2022 | Option Exercise | $4.11 | 2,333 | 9,579 | 37,888 | Feb 02, 2022, 05:20 PM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | Feb 01, 2022 | Option Exercise | $0.30 | 10,000 | 3,000 | 73,855 | Feb 02, 2022, 05:20 PM | |
| GTHX | G1 Therapeutics, Inc. | Hanson James S. | General Counsel | Jan 05, 2022 | Sale | $10.61 | 1,445 | 15,334 | 25,555 | Jan 05, 2022, 08:48 PM | |
| GTHX | G1 Therapeutics, Inc. | MURDOCK TERRY L | Chief Operating Officer | Jan 05, 2022 | Sale | $10.61 | 1,445 | 15,334 | 21,555 | Jan 05, 2022, 08:25 PM | |
| GTHX | G1 Therapeutics, Inc. | Moses Jennifer K. | CFO | Jan 05, 2022 | Sale | $10.61 | 1,445 | 15,334 | 35,555 | Jan 05, 2022, 08:25 PM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | Jan 05, 2022 | Sale | $10.61 | 1,445 | 15,334 | 63,855 | Jan 05, 2022, 08:24 PM | |
| GTHX | G1 Therapeutics, Inc. | Avagliano Mark | Chief Business Officer | Jan 05, 2022 | Sale | $10.61 | 1,445 | 15,334 | 21,555 | Jan 05, 2022, 08:24 PM | |
| GTHX | G1 Therapeutics, Inc. | Bailey John E. (Jack) Jr. | President and CEO | Jan 03, 2022 | Sale | $10.41 | 34,125 | 355,262 | 233,208 | Jan 05, 2022, 08:24 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Director | Nov 09, 2021 | Option Exercise | $0.39 | 40,000 | 15,600 | 101,000 | Nov 10, 2021, 04:05 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Director | Jul 15, 2021 | Option Exercise | $9.44 | 20,000 | 188,798 | 71,000 | Jul 15, 2021, 04:01 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Director | Jul 13, 2021 | Option Exercise | $9.92 | 20,000 | 198,436 | 71,000 | Jul 15, 2021, 04:01 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Director | Jul 14, 2021 | Option Exercise | $9.74 | 20,000 | 194,724 | 71,000 | Jul 15, 2021, 04:01 PM | |
| GTHX | G1 Therapeutics, Inc. | RUDNICK SETH | Director | Jun 29, 2021 | Option Exercise | $11.36 | 20,000 | 227,194 | 14,389 | Jun 30, 2021, 04:05 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Director | Jun 16, 2021 | Option Exercise | $11.06 | 20,000 | 221,284 | 71,000 | Jun 17, 2021, 04:05 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Director | Jun 17, 2021 | Sale | $11.08 | 20,000 | 221,628 | 71,000 | Jun 17, 2021, 04:05 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Director | Jun 15, 2021 | Option Exercise | $11.39 | 20,000 | 227,809 | 71,000 | Jun 17, 2021, 04:05 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Director | May 25, 2021 | Option Exercise | $0.39 | 20,000 | 7,800 | 61,000 | May 25, 2021, 06:29 PM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | Apr 22, 2021 | Sale | $11.23 | 30,000 | 336,949 | 58,300 | Apr 23, 2021, 04:39 PM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | Mar 23, 2021 | Sale | $11.16 | 30,000 | 334,909 | 58,300 | Mar 24, 2021, 04:47 PM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | Mar 02, 2021 | Sale | $12.25 | 30,000 | 367,411 | 58,300 | Mar 04, 2021, 05:10 PM | |
| GTHX | G1 Therapeutics, Inc. | Moses Jennifer K. | CFO | Mar 03, 2021 | Option Exercise | $3.72 | 3,000 | 11,160 | 25,000 | Mar 04, 2021, 04:54 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Director | Feb 16, 2021 | Sale | $19.46 | 22,080 | 429,722 | 52,040 | Feb 18, 2021, 05:49 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Director | Feb 17, 2021 | Sale | $15.68 | 20,000 | 313,633 | 51,000 | Feb 18, 2021, 05:49 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Director | Feb 18, 2021 | Sale | $14.87 | 20,000 | 297,352 | 51,000 | Feb 18, 2021, 05:49 PM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | Jan 27, 2021 | Option Exercise | $0.39 | 3,100 | 1,209 | 43,300 | Jan 29, 2021, 04:07 PM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Chief Medical Officer | Jan 22, 2021 | Option Exercise | $12.40 | 30,000 | 372,141 | 55,200 | Jan 22, 2021, 06:47 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Director | Jan 19, 2021 | Sale | $12.30 | 20,000 | 245,981 | 47,000 | Jan 21, 2021, 05:31 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Director | Jan 20, 2021 | Sale | $10.58 | 24,000 | 253,867 | 47,000 | Jan 21, 2021, 05:31 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | Director | Jan 21, 2021 | Option Exercise | $12.18 | 20,000 | 243,600 | 51,000 | Jan 21, 2021, 05:31 PM | |
| GTHX | G1 Therapeutics, Inc. | RUDNICK SETH | Director | Dec 24, 2020 | Sale | $20.10 | 924 | 18,572 | 5,266 | Dec 29, 2020, 04:50 PM | |
| GTHX | G1 Therapeutics, Inc. | RUDNICK SETH | Director | Dec 23, 2020 | Sale | $20.18 | 13,118 | 264,757 | 6,190 | Dec 23, 2020, 06:54 PM | |
| GTHX | G1 Therapeutics, Inc. | RUDNICK SETH | Director | Dec 22, 2020 | Sale | $20.33 | 18,974 | 385,702 | 19,308 | Dec 23, 2020, 06:54 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | President and CEO | Dec 15, 2020 | Sale | $11.57 | 20,000 | 231,497 | 47,000 | Dec 17, 2020, 06:01 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | President and CEO | Dec 16, 2020 | Sale | $11.46 | 20,000 | 229,221 | 47,000 | Dec 17, 2020, 06:01 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | President and CEO | Dec 17, 2020 | Sale | $11.84 | 20,000 | 236,868 | 47,000 | Dec 17, 2020, 06:01 PM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Ch. Medical Officer & SVP R&D | Dec 10, 2020 | Sale | $12.12 | 18,000 | 218,080 | 38,200 | Dec 11, 2020, 04:50 PM | |
| GTHX | G1 Therapeutics, Inc. | RUDNICK SETH | Director | Dec 08, 2020 | Sale | $20.19 | 13,161 | 265,694 | 44,601 | Dec 10, 2020, 05:30 PM | |
| GTHX | G1 Therapeutics, Inc. | RUDNICK SETH | Director | Dec 09, 2020 | Sale | $20.32 | 5,773 | 117,284 | 38,828 | Dec 10, 2020, 05:30 PM | |
| GTHX | G1 Therapeutics, Inc. | RUDNICK SETH | Director | Dec 10, 2020 | Sale | $20.00 | 546 | 10,921 | 38,282 | Dec 10, 2020, 05:30 PM | |
| GTHX | G1 Therapeutics, Inc. | RUDNICK SETH | Director | Dec 01, 2020 | Sale | $20.09 | 520 | 10,449 | 57,762 | Dec 03, 2020, 04:20 PM | |
| GTHX | G1 Therapeutics, Inc. | MUIR GLENN P | Director | Nov 18, 2020 | Buy | $13.50 | 50,000 | 675,000 | 170,969 | Nov 19, 2020, 04:54 PM | |
| GTHX | G1 Therapeutics, Inc. | Bailey John E. (Jack) Jr. | Director | Nov 10, 2020 | Buy | $12.76 | 4,000 | 51,055 | 4,000 | Nov 13, 2020, 04:33 PM | |
| GTHX | G1 Therapeutics, Inc. | Bailey John E. (Jack) Jr. | Director | Nov 11, 2020 | Buy | $12.83 | 4,000 | 51,320 | 8,000 | Nov 13, 2020, 04:33 PM | |
| GTHX | G1 Therapeutics, Inc. | Hanson James S. | General Counsel | Sep 04, 2020 | Buy | $14.95 | 1,000 | 14,950 | 4,000 | Sep 08, 2020, 08:38 PM | |
| GTHX | G1 Therapeutics, Inc. | Moses Jennifer K. | CFO | Mar 13, 2020 | Option Exercise | $3.72 | 2,000 | 7,440 | 11,000 | Mar 16, 2020, 07:00 AM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Ch. Medical Officer & SVP R&D | Mar 13, 2020 | Option Exercise | $0.39 | 2,500 | 975 | 29,200 | Mar 16, 2020, 07:00 AM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | President and CEO | Mar 13, 2020 | Option Exercise | $0.39 | 3,000 | 1,170 | 37,000 | Mar 16, 2020, 07:00 AM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | President and CEO | Jan 23, 2020 | Option Exercise | $0.39 | 6,000 | 2,340 | 34,000 | Jan 24, 2020, 04:59 PM | |
| GTHX | G1 Therapeutics, Inc. | Moses Jennifer K. | CFO | Jan 23, 2020 | Option Exercise | $3.72 | 1,000 | 3,720 | 9,000 | Jan 24, 2020, 04:58 PM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Ch. Medical Officer & SVP R&D | Jan 23, 2020 | Option Exercise | $0.39 | 5,000 | 1,950 | 26,700 | Jan 24, 2020, 04:58 PM | |
| GTHX | G1 Therapeutics, Inc. | Moses Jennifer K. | CFO | Jul 18, 2019 | Option Exercise | $3.72 | 2,000 | 7,440 | 8,000 | Jul 19, 2019, 09:58 PM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Ch. Medical Officer & SVP R&D | Jan 28, 2019 | Option Exercise | $0.39 | 7,000 | 2,730 | 21,700 | Jan 28, 2019, 09:10 PM | |
| GTHX | G1 Therapeutics, Inc. | Moses Jennifer K. | VP of Finance | Jan 17, 2019 | Option Exercise | $3.72 | 2,000 | 7,440 | 6,000 | Jan 17, 2019, 05:52 PM | |
| GTHX | G1 Therapeutics, Inc. | Velleca Mark A. | President and CEO | Jan 17, 2019 | Option Exercise | $0.39 | 9,000 | 3,510 | 28,000 | Jan 17, 2019, 05:52 PM | |
| GTHX | G1 Therapeutics, Inc. | Strum Jay | Chief Scientific Officer | Jan 02, 2019 | Option Exercise | $0.35 | 79,818 | 27,575 | 129,237 | Jan 02, 2019, 05:46 PM | |
| GTHX | G1 Therapeutics, Inc. | Hanson James S. | General Counsel | Dec 26, 2018 | Buy | $18.25 | 1,000 | 18,250 | 3,000 | Dec 27, 2018, 04:59 PM | |
| GTHX | G1 Therapeutics, Inc. | Schwalm Cynthia | Director | Dec 26, 2018 | Buy | $18.45 | 1,420 | 26,196 | 1,500 | Dec 27, 2018, 04:59 PM | |
| GTHX | G1 Therapeutics, Inc. | Malik Rajesh | Ch. Medical Officer & SVP R&D | Dec 17, 2018 | Option Exercise | $17.09 | 7,552 | 129,026 | 18,476 | Dec 17, 2018, 04:27 PM | |
| GTHX | G1 Therapeutics, Inc. | Hanson James S. | General Counsel | Dec 10, 2018 | Buy | $32.51 | 1,000 | 32,508 | 2,000 | Dec 11, 2018, 04:08 PM | |
| GTHX | G1 Therapeutics, Inc. | DEMAREE JOHN | Chief Commercial Officer | Dec 10, 2018 | Buy | $33.15 | 1,000 | 33,151 | 5,250 | Dec 11, 2018, 04:08 PM | |
| GTHX | G1 Therapeutics, Inc. | Moses Jennifer K. | VP of Finance & Admin | Dec 06, 2018 | Option Exercise | $17.19 | 1,500 | 25,792 | 2,750 | Dec 07, 2018, 04:07 PM | |
| GTHX | G1 Therapeutics, Inc. | Moses Jennifer K. | VP of Finance & Admin | Dec 07, 2018 | Option Exercise | $3.72 | 2,000 | 7,440 | 4,000 | Dec 07, 2018, 04:07 PM | |
| GTHX | G1 Therapeutics, Inc. | RUDNICK SETH | Director | Dec 04, 2018 | Sale | $19.85 | 20,000 | 397,046 | 10,000 | Dec 04, 2018, 06:10 PM | |
| GTHX | G1 Therapeutics, Inc. | MURDOCK TERRY L | SVP of Development Operations | Dec 03, 2018 | Option Exercise | $26.03 | 7,046 | 183,375 | 3,523 | Dec 03, 2018, 06:25 PM |
Menu